Keith Pfister

570 total citations
9 papers, 207 citations indexed

About

Keith Pfister is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Keith Pfister has authored 9 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Keith Pfister's work include Protein Kinase Regulation and GTPase Signaling (2 papers), Ubiquitin and proteasome pathways (2 papers) and Cancer therapeutics and mechanisms (1 paper). Keith Pfister is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (2 papers), Ubiquitin and proteasome pathways (2 papers) and Cancer therapeutics and mechanisms (1 paper). Keith Pfister collaborates with scholars based in United States, Switzerland and Germany. Keith Pfister's co-authors include Paul G. Gassman, S. J. Burns, Allan S. Wagman, Johanna M. Jansen, Zhi‐Jie Ni, Simon S.M. Ng, Sabina Pecchi, Dirksen E. Bussiere, Savithri Ramurthy and Paul A. Barsanti and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Journal of Medicinal Chemistry.

In The Last Decade

Keith Pfister

9 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Pfister United States 7 118 114 28 19 17 9 207
Barbara Czakó United States 9 158 1.3× 119 1.0× 33 1.2× 10 0.5× 23 1.4× 16 287
Gilles Ouvry France 10 232 2.0× 106 0.9× 32 1.1× 19 1.0× 9 0.5× 26 342
Allan Dishington United Kingdom 9 132 1.1× 131 1.1× 52 1.9× 9 0.5× 9 0.5× 17 244
Jeffrey Varnes United States 11 122 1.0× 97 0.9× 46 1.6× 16 0.8× 28 1.6× 20 260
Xiaolin Hao United States 9 193 1.6× 165 1.4× 11 0.4× 11 0.6× 21 1.2× 15 283
Dominik Hauser Germany 10 232 2.0× 188 1.6× 28 1.0× 49 2.6× 15 0.9× 11 347
N. Chessum United Kingdom 10 155 1.3× 181 1.6× 54 1.9× 15 0.8× 16 0.9× 11 335
Wooseok Han United States 10 306 2.6× 91 0.8× 41 1.5× 18 0.9× 10 0.6× 14 385
Andrew P. Osnowski United Kingdom 4 121 1.0× 82 0.7× 59 2.1× 22 1.2× 21 1.2× 4 212
Loka Reddy Velatooru India 10 209 1.8× 112 1.0× 38 1.4× 7 0.4× 14 0.8× 19 350

Countries citing papers authored by Keith Pfister

Since Specialization
Citations

This map shows the geographic impact of Keith Pfister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Pfister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Pfister more than expected).

Fields of papers citing papers by Keith Pfister

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Pfister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Pfister. The network helps show where Keith Pfister may publish in the future.

Co-authorship network of co-authors of Keith Pfister

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Pfister. A scholar is included among the top collaborators of Keith Pfister based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Pfister. Keith Pfister is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ramurthy, Savithri, Keith Pfister, Sean P. Brown, et al.. (2019). Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(4). 126930–126930. 11 indexed citations
2.
Jansen, Johanna M., Gianfranco De Pascale, Susan Fong, et al.. (2019). Biased Complement Diversity Selection for Effective Exploration of Chemical Space in Hit-Finding Campaigns. Journal of Chemical Information and Modeling. 59(5). 1709–1714. 10 indexed citations
3.
Han, Wooseok, Yu Ding, Yongjin Xu, et al.. (2016). Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design. Journal of Medicinal Chemistry. 59(7). 3034–3045. 15 indexed citations
4.
Altmann, Eva, P. Erbel, Martin Renatus, et al.. (2016). Azaindoles as Zinc‐Binding Small‐Molecule Inhibitors of the JAMM Protease CSN5. Angewandte Chemie. 129(5). 1314–1317. 1 indexed citations
5.
Altmann, Eva, P. Erbel, Martin Renatus, et al.. (2016). Azaindoles as Zinc‐Binding Small‐Molecule Inhibitors of the JAMM Protease CSN5. Angewandte Chemie International Edition. 56(5). 1294–1297. 20 indexed citations
6.
Möser, Christina, et al.. (2011). Effects of ASA404, a vascular disrupting agent, on tumor growth of gastric cancer in an experimental model.. Journal of Clinical Oncology. 29(4_suppl). 48–48. 2 indexed citations
7.
Burger, Matthew T., Mark Knapp, Allan S. Wagman, et al.. (2010). Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-kinase Inhibitors. ACS Medicinal Chemistry Letters. 2(1). 34–38. 23 indexed citations
8.
Ni, Zhi‐Jie, Paul A. Barsanti, Daniel J. Poon, et al.. (2006). 4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(12). 3121–3124. 58 indexed citations
9.
Gassman, Paul G., S. J. Burns, & Keith Pfister. (1993). Synthesis of cyclic and acyclic enol ethers (vinyl ethers). The Journal of Organic Chemistry. 58(6). 1449–1457. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026